Brief: Erytech Announces First Patient Enrolled In Phase 1 Trial Of Eryaspase

Phaxiam Therapeutics SA

14/01/2021 21:50

Jan 14 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH ANNOUNCES FIRST PATIENT ENROLLED IN A PHASE 1
INVESTIGATOR SPONSORED TRIAL OF ERYASPASE IN FIRST-LINE
PANCREATIC CANCER

Source text for Eikon:  ID:nGNX4P1Nmt 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))